Positive impact on lives and healthcare budgets.
Podimetrics is bringing new hope to patients, payors and providers. View our favorite highlights below or see all our clinical evidence.
Reduced Complications and Amputations
In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:
Patient Experience and Adherence
In two different studies:
engaged at one year2
SmartMat “easy to use”3
Reduced Complications and Amputations
In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:
52% relative risk reduction1
† Net difference was observed despite 1.6 additional podiatry outpatient visits per-participant year resulting from inflammation detected by the study device.
Cost Savings and ROI
Podimetrics calculates up to $13,000 in annual cost savings per patient4
3.6X – 5.2X
$9,800 – 14,000
Choose innovation.
Not complications and amputations.
Learn MoreWhat's new at Podimetrics?
All NewsWhat Can Patients Teach Providers About Improving DFU Care?
Patient perspectives reveal critical gaps in diabetic foot ulcer care, highlighting the need for clearer education, earlier intervention, and more…Provider Burnout: Recognizing the Signal Before It Escalates
A closer look at healthcare burnout, what drives it, how to recognize early warning signs, and the steps individuals and…Guest Blog from Allegiance Group + Pursuant–Storytelling for Healthcare Orgs: 5 Ethical Considerations
Stories engage people, drive connections, and build trust—all of which are important factors in your healthcare organization’s success. Whether you…
What Can Patients Teach Providers About Improving DFU Care?
Patient perspectives reveal critical gaps in diabetic foot ulcer care, highlighting the need for clearer education, earlier intervention, and more…
1. Isaac, et al. BMJ Open Diab Res Care 2020
2. Rothenberg, et al. Fed Pract. 2020
3. Frykberg, et al. Diabetes Care 2017
4. Podimetrics Data on File
5. Assumptions based on 90 weeks of Intermountain Health claims data for 428 at-risk patients and applying results from our recent peer-reviewed study with Kaiser Permanente in the British Journal of Medicine (BMJ)